COVID-19 test provider selloff on Abbott approval overdone, says Piper FLDM, QDEL, FLGT, LMNX, VIVO, ABT After the FDA yesterday approved Abbott's rapid antigen test, companies with COVID-19 tests sold off, many of which pulled back 30%, Piper Sandler analyst Steven Mah tells investors in a research note. The analyst believes this is an overreaction and presents a buying opportunity for test providers Quidel (QDEL), Fluidigm (FLDM), Fulgent Genetics (FLGT), and Luminex (LMNX), and companies that provide COVID-19 testing reagents, such as Meridian Bioscience (VIVO).
Everyone except OSUR it seems... If I was Pfizer I would buy OSUR ASAP.
While acknowledging the low-price and scalability of Abbott's lateral flow test in terms of patient access, Mah notes that many of the companies above already have long-term COVID-19 testing contracts.
/ / /
VAN DO WE " GROW " Again?
-- I have some money that should be clearing 3 day hold period and I need a Big winner.
-The Schall Law Firm, a national shareholder rights litigation firm, announced today that it has closed its investigation into claims against GrowGeneration Corp. ("GrowGeneration" or "the Company") (NASDAQ:GRWG) for violations of securities laws, as its investigation did not uncover any evidence of securities laws violations. No lawsuit regarding this matter has been filed against the Company or its officers and directors.
GrowGeneration Corp. (GRWG)?
16.34+1.28 (+8.53%)
At close: August 28 4:00PM EDT
Everyone except OSUR it seems... If I was Pfizer I would buy OSUR ASAP.
While acknowledging the low-price and scalability of Abbott's lateral flow test in terms of patient access, Mah notes that many of the companies above already have long-term COVID-19 testing contracts.
/ / /
VAN DO WE " GROW " Again?
-- I have some money that should be clearing 3 day hold period and I need a Big winner.
-The Schall Law Firm, a national shareholder rights litigation firm, announced today that it has closed its investigation into claims against GrowGeneration Corp. ("GrowGeneration" or "the Company") (NASDAQ:GRWG) for violations of securities laws, as its investigation did not uncover any evidence of securities laws violations. No lawsuit regarding this matter has been filed against the Company or its officers and directors.
GrowGeneration Corp. (GRWG)?
16.34+1.28 (+8.53%)
At close: August 28 4:00PM EDT